Literature DB >> 17596616

Rituximab in patients with the steroid-resistant nephrotic syndrome.

Arvind Bagga, Aditi Sinha, Asha Moudgil.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17596616     DOI： 10.1056/NEJMc063706

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  67 in total

1.  Rituximab for refractory cases of childhood nephrotic syndrome.

Authors:  Jameela A Kari; Salah M El-Morshedy; Sherif El-Desoky; Hammad O Alshaya; Khawla A Rahim; Burhan M Edrees
Journal:  Pediatr Nephrol       Date:  2011-01-31       Impact factor: 3.714

2.  Fatal pulmonary fibrosis after rituximab administration.

Authors:  Marie-Camille Chaumais; Arnaud Garnier; François Chalard; Michel Peuchmaur; Stephane Dauger; Evelyne Jacqz-Agrain; Georges Deschênes
Journal:  Pediatr Nephrol       Date:  2009-04-25       Impact factor: 3.714

Review 3.  Rituximab therapy for refractory steroid-resistant nephrotic syndrome in children.

Authors:  Koichi Kamei; Kenji Ishikura; Mayumi Sako; Shuichi Ito; Kandai Nozu; Kazumoto Iijima
Journal:  Pediatr Nephrol       Date:  2018-12-18       Impact factor: 3.714

Review 4.  New therapies in steroid-sensitive and steroid-resistant idiopathic nephrotic syndrome.

Authors:  Michael van Husen; Markus J Kemper
Journal:  Pediatr Nephrol       Date:  2011-01-13       Impact factor: 3.714

5.  The Evolving Role of Rituximab in Adult Minimal Change Glomerulopathy.

Authors:  Landon C Brown; Meghan A Jobson; Fernanda Payan Schober; Emily H Chang; Ronald J Falk; Patrick H Nachman; William F Pendergraft
Journal:  Am J Nephrol       Date:  2017-03-18       Impact factor: 3.754

Review 6.  Rituximab in immunologic glomerular diseases.

Authors:  A Ahsan Ejaz; Abdo Asmar; Mourad M Alsabbagh; Nasimul Ahsan
Journal:  MAbs       Date:  2012-03-01       Impact factor: 5.857

7.  Relapse of nephrotic syndrome during post-rituximab peripheral blood B-lymphocyte depletion.

Authors:  Mai Sato; Koichi Kamei; Masao Ogura; Kenji Ishikura; Shuichi Ito
Journal:  Clin Exp Nephrol       Date:  2017-04-22       Impact factor: 2.801

Review 8.  Treatment of steroid-resistant nephrotic syndrome in the genomic era.

Authors:  Adam R Bensimhon; Anna E Williams; Rasheed A Gbadegesin
Journal:  Pediatr Nephrol       Date:  2018-10-02       Impact factor: 3.714

9.  Efficacy of rituximab therapy in children with refractory nephrotic syndrome: a prospective observational study in Shanghai.

Authors:  Li Sun; Hong Xu; Qian Shen; Qi Cao; Jia Rao; Hai-Mei Liu; Xiao-Yan Fang; Li-Jun Zhou
Journal:  World J Pediatr       Date:  2014-01-25       Impact factor: 2.764

10.  Rituximab treatment of collapsing C1q glomerulopathy: clinical and histopathological evolution.

Authors:  Martin Bitzan; Jodie D Ouahed; Preetha Krishnamoorthy; Chantal Bernard
Journal:  Pediatr Nephrol       Date:  2008-03-20       Impact factor: 3.714
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.